Inspec

Inspec FCF Yield

The Free Cash Flow Yield of Inspec (6656.T) as of Oct 21, 2026 is -23.38 %. In the previous year, Free Cash Flow Yield was 18.70 % — a change of -225.03% (lower).

FCF Yield

-23.38 %

YoY

-225.03%

Last updated:

Free Cash Flow Yield of Inspec is 2026 -23.38 % . Free Cash Flow Yield of Inspec was 2025 18.70 % . It decreases by -225.03% lower compared to the previous year.

The Inspec FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2019
17.83 JPY
Jan 1, 2020
-15.42 JPY
Jan 1, 2021
-12.23 JPY
Jan 1, 2022
-19.36 JPY
Jan 1, 2023
-29.43 JPY
Jan 1, 2024
0.79 JPY
Jan 1, 2025
18.70 JPY
Jan 1, 2026
-23.38 JPY
The Inspec FCF Yield history
YEARFCF YieldYoY
-23.38 %-225.03%
18.70 %+2,263.08%
0.79 %-102.69%
-29.43 %+51.98%
-19.36 %+58.38%
-12.23 %-20.72%
-15.42 %-186.49%
17.83 %-182.57%
-21.59 %-300.48%
10.77 %+177.64%
3.88 %-181.50%
-4.76 %-44.93%
-8.64 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Inspec Stock analysis

What does Inspec do? inspec Inc. generates revenue through three primary segments. The Semiconductor Package Substrates and Precision Substrate Inspection Equipment segment sells appearance inspection equipment for semiconductor package substrates and precision printed circuit boards used in smartphones, tablets, PCs, and wearable terminals. The Precision Substrate Manufacturing Equipment segment provides photoplotters, inkjet printers, and direct imaging devices along with maintenance services for printed circuit boards. The Digital Pathology Related Equipment segment develops and sells medical image processing systems, specifically whole slide imaging (WSI) for digital pathology applications. Customers include manufacturers of advanced digital devices requiring semiconductor inspection, PCB producers needing photoplotters and imaging devices, and healthcare providers utilizing whole slide imaging systems for pathology diagnostics. The company's products target the semiconductor, electronics manufacturing, and medical imaging sectors with specific applications in device assembly, PCB production, and medical diagnostics. inspec Inc. focuses on equipment for semiconductor package substrates, precision substrates, and digital pathology, serving clients in the electronics and healthcare industries. The firm's inspection and imaging solutions are tailored to meet the quality control needs of high-tech manufacturing and medical diagnostics, with no mention of additional revenue streams beyond these three segments. Inspec is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Inspec stock

Free Cash Flow Yield of Inspec is -23.38 % in 2026.

Free Cash Flow Yield of Inspec changed from 18.70 % to -23.38 %, representing a -225.03% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Inspec since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Inspec with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Inspec

All Key Metrics — Inspec